Tesaro, Inc.

Top Publications

Top Publications Authored or Co-Authored in "Tesaro, Inc."

• Oncogenic Signaling Pathways in The Cancer Genome Atlas

  Cell, Volume 173, No. 2, Year 2018, Citations 1646
• Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

  Cell Reports, Volume 23, No. 1, Year 2018, Citations 612
• Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: Two randomised, active-controlled, double-blind, phase 3 trials

  The Lancet Oncology, Volume 16, No. 9, Article 38, Year 2015, Citations 127
• Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: A randomised, active-controlled, double-blind, phase 3 trial

  The Lancet Oncology, Volume 16, No. 9, Article 37, Year 2015, Citations 126
• Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC)

  Supportive Care in Cancer, Volume 23, No. 11, Year 2015, Citations 67